FDA officials were recently made aware of regulatory issues of concern to dietary supplement trade groups, including the marketing of “tainted” products.
Axios report: Burr says no chance of 2022 dietary supplement reform naturalproductsinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naturalproductsinsider.com Daily Mail and Mail on Sunday newspapers.
The debacle facing NMN supplement brands reflects growing concerns over a drug "exclusion" provision in U.S. law that FDA concluded is applicable to β-NMN.
All it will take for critics of the dietary supplement industry to accelerate their plans to undo DSHEA is another crisis like ephedra, writes Jon Benninger.
FDA relied, in part, on remote regulatory assessments of dietary supplement facilities during the pandemic, but RRAs of supplement firms decreased in FY22.